BMO Capital raises Ionis Pharmaceuticals price target to $61
BMO Capital raised its price target on Ionis Pharmaceuticals to $61.00 per share from $60.00 and maintained its Market Perform rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.